IDEXX Laboratories Inc. Company Profile
NASDAQ: IDXXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
IDEXX Laboratories at a glance
IDEXX Laboratories Inc. (NASDAQ: IDXX) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company in the Health Care sector headquartered in Westbrook, ME. IDEXX Laboratories is led by Mr. Michael G. Erickson Ph.D. and employs about 11,000 people. The company's shares have traded publicly since 1991.
At a market capitalization of $40.43 billion, it is considered a large-cap company. IDXX is a member of the SP500, NDX. Its SEC Central Index Key (CIK) is 0000874716, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does IDEXX Laboratories do?
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Business description based on the company's public filings.
Company information
- Legal name
- IDEXX Laboratories Inc.
- Ticker
- NASDAQ: IDXX
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CEO
- Mr. Michael G. Erickson Ph.D.
- Employees
- 11,000
- Headquarters
- One IDEXX Drive, Westbrook, ME, United States
- Phone
- 207 556 0300
- Website
- idexx.com
- IPO year
- 1991
- Market cap
- $40.43B
- SEC CIK
- 0000874716
- Latest annual report
- 10-K · Feb 20, 2026
Index membership
Companies similar to IDEXX Laboratories
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LNTHLantheus Holdings Inc. | 100.15 | +0.03% | $6.54B | vs IDXX |
| ORKAOruka Therapeutics Inc. | 82.11 | +6.25% | $5.44B | vs IDXX |
| NEOGNeogen Corporation | 11.85 | +1.20% | $2.59B | vs IDXX |
| CLDXCelldex Therapeutics Inc. | 29.89 | +2.01% | $2.35B | vs IDXX |
| NTLAIntellia Therapeutics Inc. | 13.07 | +3.73% | $1.83B | vs IDXX |
| QDELQuidelOrtho Corporation | 13.42 | +8.14% | $920.28M | vs IDXX |
| ACHVAchieve Life Sciences Inc. | 7.41 | +3.06% | $763.99M | vs IDXX |
| TKNOAlpha Teknova Inc. | 8.84 | +4.74% | $474.60M | vs IDXX |